---
schema_version: "secwatch.filing_event.v1"
accession: "0001625297-25-000042"
form_type: "8-K"
ticker: "INDV"
cik: "0001625297"
company_name: "Indivior Pharmaceuticals, Inc."
filed_at: "2025-06-24T23:59:59+00:00"
generated_at: "2026-05-18T22:39:39.090239+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Indivior appoints Tony Kingsley to board; directors adopt equity purchase plan

## Summary
- Appointed Tony Kingsley as independent non-executive director effective July 1, 2025.
- Kingsley appointed per Oaktree relationship agreement; former CEO of Scholar Rock and Stablix.
- Five US non-executive directors entered JP Morgan purchase plan; company funds ~70% of after-tax retainer into shares.
- UK director Juliet Thompson bought 1,925 shares on June 11; company to reimburse over next year.

## SEC filing metadata
- accession: 0001625297-25-000042
- form_type: 8-K
- ticker: INDV
- cik: 0001625297
- company_name: Indivior Pharmaceuticals, Inc.
- filed_at: 2025-06-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625297/000162529725000042/0001625297-25-000042-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625297/000162529725000042/indv-20250620.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001625297-25-000042
- JSON: https://secwatch.observer/filing/0001625297-25-000042.json
- Plain text: https://secwatch.observer/filing/0001625297-25-000042.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.